Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 201
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Detection of Zika virus rapidly without the need for a laboratory in Brazil

Zika (PORTUGUESE) is a rapidly emerging pandemic, a global health emergency. ZIKV has been associated with central...

How does our blood absorb light?

Light has been shown to have anti-depressant effects (just think about your mood when it's sunny!). But we still...

StarScaffold - Creating Better Multi Protein Structures

StarScaffold is a scaffold protein designed to specifically link other proteins to itself. It’s a platform technology...

Backer Badge Funded